214 related articles for article (PubMed ID: 31422498)
1. Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform.
Swellam M; Ezz El Arab L; Al-Posttany AS; B Said S
J Neurooncol; 2019 Sep; 144(3):545-551. PubMed ID: 31422498
[TBL] [Abstract][Full Text] [Related]
2. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of miRNAs as liquid biopsy markers for prediction of glioblastoma multiforme prognosis.
Swellam M; Bakr NM; El Magdoub HM; Hamza MS; Ezz El Arab LR
J Mol Neurosci; 2021 Apr; 71(4):836-844. PubMed ID: 32989634
[TBL] [Abstract][Full Text] [Related]
4. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
Zhang H; Wang J; Wang Z; Ruan C; Wang L; Guo H
Cancer Biomark; 2019; 24(1):43-49. PubMed ID: 30530966
[TBL] [Abstract][Full Text] [Related]
5. Relevance of circulating MiRNA-21 and MiRNA-181 in prediction of glioblastoma multiforme prognosis.
Labib EM; Ezz El Arab LR; Ghanem HM; Hassan RE; Swellam M
Arch Physiol Biochem; 2022 Aug; 128(4):924-929. PubMed ID: 32316783
[TBL] [Abstract][Full Text] [Related]
6. Circulating miR-26a and miR-21 as biomarkers for glioblastoma multiform.
ParvizHamidi M; Haddad G; Ostadrahimi S; Ostadrahimi N; Sadeghi S; Fayaz S; Fard-Esfahani P
Biotechnol Appl Biochem; 2019 Mar; 66(2):261-265. PubMed ID: 30408234
[TBL] [Abstract][Full Text] [Related]
7. Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.
Jin Z; Jin RH; Ma C; Li HS; Xu HY
J BUON; 2017; 22(2):474-480. PubMed ID: 28534372
[TBL] [Abstract][Full Text] [Related]
8. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
[TBL] [Abstract][Full Text] [Related]
9. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.
Chen J; Yang L; Wang X
Cancer Biomark; 2017 Dec; 20(4):521-526. PubMed ID: 28946553
[TBL] [Abstract][Full Text] [Related]
10. MiR-330-3p and miR-485-5p as biomarkers for glioblastoma: An integrated bioinformatics and experimental study.
Rahmati Y; Alivand M; Mollanoori H
Comput Biol Chem; 2021 Jun; 92():107458. PubMed ID: 33761401
[TBL] [Abstract][Full Text] [Related]
11. Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients.
Hallal S; Ebrahim Khani S; Wei H; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668808
[TBL] [Abstract][Full Text] [Related]
12. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
13. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma.
Wang Q; Li P; Li A; Jiang W; Wang H; Wang J; Xie K
J Exp Clin Cancer Res; 2012 Nov; 31(1):97. PubMed ID: 23174013
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin.
Herman A; Gruden K; Blejec A; Podpečan V; Motaln H; Rožman P; Hren M; Zupančič K; Veber M; Verbovšek U; Lah Turnšek T; Porčnik A; Koršič M; Knežević M; Jeras M
PLoS One; 2015; 10(5):e0125791. PubMed ID: 25950799
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
16. Short non-coding RNA sequencing of glioblastoma extracellular vesicles.
de Mooij T; Peterson TE; Evans J; McCutcheon B; Parney IF
J Neurooncol; 2020 Jan; 146(2):253-263. PubMed ID: 31912278
[TBL] [Abstract][Full Text] [Related]
17. MiR-106a is an independent prognostic marker in patients with glioblastoma.
Zhao S; Yang G; Mu Y; Han D; Shi C; Chen X; Deng Y; Zhang D; Wang L; Liu Y; Hou X; Wang C; Wu J; Liu H; Wang L; Zhang G; Qi J; Fang X; Shi C; Ai J
Neuro Oncol; 2013 Jun; 15(6):707-17. PubMed ID: 23416698
[TBL] [Abstract][Full Text] [Related]
18. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool.
Manterola L; Guruceaga E; Gállego Pérez-Larraya J; González-Huarriz M; Jauregui P; Tejada S; Diez-Valle R; Segura V; Samprón N; Barrena C; Ruiz I; Agirre A; Ayuso A; Rodríguez J; González A; Xipell E; Matheu A; López de Munain A; Tuñón T; Zazpe I; García-Foncillas J; Paris S; Delattre JY; Alonso MM
Neuro Oncol; 2014 Apr; 16(4):520-7. PubMed ID: 24435880
[TBL] [Abstract][Full Text] [Related]
19. miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
Dong L; Li Y; Han C; Wang X; She L; Zhang H
Int J Oncol; 2014 Aug; 45(2):746-56. PubMed ID: 24858071
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNA-137 is a potential biomarker for human glioblastoma.
Li HY; Li YM; Li Y; Shi XW; Chen H
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3599-604. PubMed ID: 27649660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]